Magdy Selim et al. Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial. The Lancet Neurology.
March 18, 2019
How Analyze was Used
“Areas of the haematoma and perihaematomal oedema were automatically delineated with imaging analysis software (Analyze 11.0 Visualization and Analysis Software for Medical Imaging; AnalyzeDirect, Overland Park, KS.)”
Intracerebral haemorrhage, Iron chelator, Deferoxamine mesylate
Beth Israel Deaconess Medical Center, Boston, MA, USA